Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GLOBEIMMUNE INC (GBIM)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
5.75
|
M
| |
-96
|
% ROE
|
| Market cap: |
|
| |
|
|
|
Net cash:
|
$8.69
|
M
| |
$1.51
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($4.6)
|
M
| |
|
|
|
EBIT
|
($4.7)
|
M
| |
|
|
| EPS |
($0.39)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 6.5 | 6.0 | 22.5 | 12.6 | 5.1 | 4.1 | 2.5 |
| Revenue growth | 8.2% | -73.5% | 78.1% | 147.5% | 25.6% | 60.0% | |
| Cost of goods sold | 2.4 | 3.5 | 5.9 | 10.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 4.1 | 2.5 | 16.7 | 2.6 | 5.1 | 4.1 | 2.5 |
| Gross margin | 63.5% | 42.1% | 74.0% | 20.6% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | | 8.6 | | | |
| Research and development | 6.3 | 9.4 | 12.7 | 1.7 | | | |
| General and administrative | 4.6 | 4.3 | 3.2 | | 4.7 | 4.4 | 5.0 |
| EBIT | -2.8 | -5.8 | 7.7 | -2.0 | -12.6 | -15.8 | -20.4 |
| EBIT margin | -42.8% | -97.5% | 34.1% | -15.9% | -246.5% | -387.3% | -801.5% |
| Pre-tax income | -2.8 | -16.3 | 9.6 | -2.0 | -13.7 | -14.8 | -22.1 |
| Income taxes | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 1.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -2.8 | -23.4 | -3.4 | 0.0 | -13.7 | 0.0 | -22.1 |
| Net margin | -42.8% | -392.8% | -15.1% | 0.0% | -268.7% | -0.6% | -870.8% |
| |
| Diluted EPS | ($0.48) | ($8.04) | ($36.84) | $0.00 | ($25,041.00) | ($68.81) | ($30,542.00) |
| Shares outstanding (diluted) | 5.8 | 2.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|